The Goldman Sachs Group Cuts Clorox (NYSE:CLX) Price Target to $110.00

Clorox (NYSE:CLX) had its price target lowered by The Goldman Sachs Group from $115.00 to $110.00 in a report released on Wednesday morning,MarketScreener reports. The brokerage currently has a sell rating on the stock.

A number of other equities research analysts have also weighed in on the stock. Zacks Research upgraded shares of Clorox from a “strong sell” rating to a “hold” rating in a report on Monday, September 29th. Jefferies Financial Group decreased their price objective on shares of Clorox from $167.00 to $145.00 and set a “buy” rating for the company in a research note on Thursday, June 26th. TD Cowen decreased their price objective on shares of Clorox from $120.00 to $117.00 and set a “hold” rating for the company in a research note on Wednesday. JPMorgan Chase & Co. increased their price objective on shares of Clorox from $133.00 to $135.00 and gave the company a “neutral” rating in a research note on Monday, September 8th. Finally, Wells Fargo & Company decreased their price objective on shares of Clorox from $130.00 to $125.00 and set an “equal weight” rating for the company in a research note on Thursday, September 25th. One research analyst has rated the stock with a Buy rating, ten have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat, Clorox presently has an average rating of “Reduce” and a consensus price target of $134.08.

Clorox Price Performance

CLX stock opened at $123.30 on Wednesday. The stock has a market capitalization of $15.08 billion, a PE ratio of 18.91, a price-to-earnings-growth ratio of 0.98 and a beta of 0.52. The company’s 50-day moving average is $122.81 and its 200-day moving average is $129.64. The company has a debt-to-equity ratio of 5.15, a current ratio of 0.84 and a quick ratio of 0.57. Clorox has a 1 year low of $116.53 and a 1 year high of $171.37.

Clorox (NYSE:CLX) last posted its earnings results on Thursday, July 31st. The company reported $2.87 earnings per share for the quarter, topping analysts’ consensus estimates of $2.24 by $0.63. Clorox had a net margin of 11.40% and a return on equity of 377.86%. The company had revenue of $1.99 billion for the quarter, compared to analyst estimates of $1.94 billion. During the same quarter in the prior year, the business posted $1.82 EPS. The firm’s revenue was up 4.5% compared to the same quarter last year. Clorox has set its FY 2026 guidance at 5.950-6.30 EPS. Equities research analysts expect that Clorox will post 7.15 EPS for the current fiscal year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 6th. Investors of record on Wednesday, October 22nd will be issued a $1.24 dividend. The ex-dividend date of this dividend is Wednesday, October 22nd. This represents a $4.96 annualized dividend and a yield of 4.0%. Clorox’s dividend payout ratio (DPR) is 76.07%.

Insider Buying and Selling

In related news, COO Eric H. Reynolds sold 15,041 shares of the firm’s stock in a transaction that occurred on Thursday, September 4th. The shares were sold at an average price of $123.78, for a total value of $1,861,774.98. Following the completion of the transaction, the chief operating officer directly owned 54,221 shares of the company’s stock, valued at approximately $6,711,475.38. This trade represents a 21.72% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Company insiders own 0.57% of the company’s stock.

Institutional Inflows and Outflows

Large investors have recently bought and sold shares of the company. Sonora Investment Management Group LLC raised its position in shares of Clorox by 2.5% during the 1st quarter. Sonora Investment Management Group LLC now owns 2,940 shares of the company’s stock valued at $433,000 after buying an additional 72 shares in the last quarter. Sumitomo Mitsui DS Asset Management Company Ltd raised its position in shares of Clorox by 0.6% during the 1st quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 13,266 shares of the company’s stock valued at $1,953,000 after buying an additional 73 shares in the last quarter. Horizon Investments LLC raised its position in Clorox by 4.4% in the 1st quarter. Horizon Investments LLC now owns 1,768 shares of the company’s stock worth $258,000 after purchasing an additional 75 shares during the period. Sfmg LLC raised its position in Clorox by 2.8% in the 1st quarter. Sfmg LLC now owns 2,780 shares of the company’s stock worth $409,000 after purchasing an additional 76 shares during the period. Finally, Hancock Whitney Corp raised its position in Clorox by 4.3% in the 1st quarter. Hancock Whitney Corp now owns 2,064 shares of the company’s stock worth $304,000 after purchasing an additional 86 shares during the period. 78.53% of the stock is owned by institutional investors.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.